1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Translational Research Program Grants is a grant from the Leukemia & Lymphoma Society that funds bench-to-bedside blood cancer research that bridges scientific discovery and clinical application. The program provides up to $200,000 per year for up to three years, supporting research that moves findings from the laboratory directly toward patient benefit.
LLS has been supporting blood cancer research since 1949 and has played an instrumental role in the development of nearly every major breakthrough in blood cancer treatment. Eligible applicants are investigators at nonprofit and academic institutions; postdoctoral fellows may apply as named scholars in collaboration with a faculty sponsor. Letters of Intent are due October 16, 2025.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Research Grant Programs | Leukemia and Lymphoma Society LLS Research Grant Programs Supporting Blood Cancer Research since 1949 Special Grants & Initiatives LLS Research Grant Programs Supporting Blood Cancer Research since 1949 Special Grants & Initiatives Our mission begins with the word cure . We recognize groundbreaking research will lead us toward the cures we seek.
For more than 70 years, LLS support has been instrumental in the development of nearly every breakthrough in blood cancer treatment. Discovery Grants Program (DGP) is now OPEN. Letters of Intent are due by August 19, 2025.
The Hairy Cell Leukemia Foundation-Leukemia & Lymphoma Society HCL2030 Initiative (HCL2030) is now OPEN. Letters of Intent are due September 3, 2025 Applications are now open for the Equity in Access Research Program. Letters of Intent are due September 11, 2025 Translational Research Program (TRP) is now OPEN.
Letters of Intent are due by October 16, 2025 The Career Development Program (CDP) is now OPEN. Eligibility Submissions due by October 17, 2025. The Student Mentorship and Research Training (SMART) Program is now Open!
Apply Now! Our Research Grant portfolio contains programs that cover blood cancer research from the earliest phase of discovery science to translational research that goes from “Bench to Bedside” directly benefiting our patients.
We also strongly believe that providing support to today's promising early-career scientists is fundamental to making sure that they will continue contributing to blood cancer research as tomorrow's leaders of the field. We announce special, disease focused RFP s (requests for proposal) on a regular basis to accelerate research areas with high unmet need.
To move the needle further and faster, LLS forms partnerships with other organizations to fund meritorious blood cancer research together: Please reach out to us via email at researchprograms@lls. org if you have any questions.
According to the current listing, eligibility includes: Investigators at nonprofit and academic institutions; postdoctoral fellows may be eligible as named scholars in collaboration with a faculty sponsor. Confirm the full requirements in the official notice before applying.
The current listing shows up to $200,000 per year for 3 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Translational Research Program Grants is funded by Leukemia & Lymphoma Society. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.